Targeted therapies on the horizon for malignant glioma Silvia HoferRoger Stupp Editorial 09 September 2010 Pages: 157 - 160
MGMT promoter methylation in malignant gliomas Markus J. RiemenschneiderMonika E. HegiGuido Reifenberger Review 20 August 2010 Pages: 161 - 165
Vascular endothelial growth factor inhibitors in malignant gliomas Priscilla K. BrastianosTracy T. Batchelor Review 07 September 2010 Pages: 167 - 174
Targeting integrins in malignant glioma Ghazaleh TabatabaiMichael WellerRoger Stupp Review 04 September 2010 Pages: 175 - 181
Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives Michael W. RonellenfitschJoachim P. SteinbachWolfgang Wick Review 19 September 2010 Pages: 183 - 191
Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas Patrick G. MorrisLauren E. Abrey Review 16 September 2010 Pages: 193 - 200
Molecular markers in gliomas: impact for the clinician Silvia HoferAndrew B. Lassman Review 31 August 2010 Pages: 201 - 210
Glioma stem cells as a target for treatment Katrin LamszusHauke S. Günther Perspectives 25 August 2010 Pages: 211 - 215
Immune therapeutic targeting of glioma cancer stem cells Mustafa Aziz HatibogluJun WeiAmy B. Heimberger Perspectives 25 August 2010 Pages: 217 - 227